Growth Metrics

Vericel (VCEL) Share-based Compensation (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Vericel 1.69 Bn 1.55 Bn 49.27 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 34.09%
Dec 31, 2025 -3.17%
Sep 30, 2025 -14.21%
Jun 30, 2025 -11.86%
Mar 31, 2025 45.32%
Dec 31, 2024 -14.17%
Sep 30, 2024 -3.11%
Jun 30, 2024 -3.19%
Mar 31, 2024 42.34%
Dec 31, 2023 -12.81%
Sep 30, 2023 -9.55%
Jun 30, 2023 0.34%
Mar 31, 2023 12.80%
Dec 31, 2022 -14.98%
Sep 30, 2022 -15.77%
Jun 30, 2022 13.40%
Mar 31, 2022 21.55%
Dec 31, 2021 -8.78%
Sep 30, 2021 -20.89%
Jun 30, 2021 54.81%
Mar 31, 2021 132.11%
Dec 31, 2020 13.05%
Sep 30, 2020 -38.87%
Jun 30, 2020 16.14%
Mar 31, 2020 22.18%
Dec 31, 2019 -6.12%
Sep 30, 2019 -21.45%
Jun 30, 2019 59.13%
Mar 31, 2019 77.09%
Dec 31, 2018 -23.19%
Sep 30, 2018 -21.62%
Jun 30, 2018 83.68%
Mar 31, 2018 114.04%
Dec 31, 2017 -16.95%
Sep 30, 2017 -5.15%
Jun 30, 2017 58.57%
Mar 31, 2017 -4.56%
Dec 31, 2016 -19.57%
Sep 30, 2016 -21.30%
Jun 30, 2016 70.29%
Mar 31, 2016 -12.70%
Dec 31, 2015 -2.61%
Sep 30, 2015 -17.05%
Jun 30, 2015 -24.95%
Mar 31, 2015 395.70%
Dec 31, 2014 -7.00%
Sep 30, 2014 0.00%
Jun 30, 2014 -25.93%
Mar 31, 2014 -32.16%
Dec 31, 2013 298.00%
Sep 30, 2013 -76.53%
Jun 30, 2013 1,090.70%
Mar 31, 2013 -109.68%
Dec 31, 2012 -60.60%
Sep 30, 2012 -7.92%
Jun 30, 2012 50.18%
Mar 31, 2012 -16.50%
Dec 31, 2011 6.20%
Sep 30, 2010 134.72%